Manulife (Manufacturers Life Insurance)
ERNA icon

Manulife (Manufacturers Life Insurance)’s Eterna Therapeutics ERNA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed -$56 – 3101
2021
Q4 		$56 Hold
2
– – ﹤0.01% 3089
2021
Q3 		$153K Hold
2
– – ﹤0.01% 3061
2021
Q2 		$252K Buy
+2
New +$288K ﹤0.01% 2944
2017
Q3 		– Hold
0
– -$1K – 4265
2017
Q2 		– Hold
0
– – – 4207
2017
Q1 		– Hold
0
– – – 4035
2016
Q4 		– Hold
0
– – – 4183
2016
Q3 		– Hold
0
– – – 4138
2016
Q2 		– Hold
0
– – – 4096
2016
Q1 		– Hold
0
– – – 4003
2015
Q4 		– Hold
0
– – – 3880
2015
Q3 		– Hold
0
– – – 3833
2015
Q2 		– Hold
0
– – – 3821
2015
Q1 		– Hold
0
– – – 3755
2014
Q4 		– Hold
0
– – – 3690
2014
Q3 		– Hold
0
– – – 3764
2014
Q2 		– Hold
0
– – – 3573
2014
Q1 		– Hold
0
– – – 3536
2013
Q4 		– Hold
0
– – – 3573

Other funds holding ERNA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $1.1B AUM 33.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ERNA Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Eterna Therapeutics (ERNA) in Q1 2022, closing a stake of 2 shares — an estimated $56 sold.

Manulife (Manufacturers Life Insurance) first reported a position in ERNA in Q2 2021 and held it in 3 quarters. The position peaked at $252K in Q2 2021. 49 funds tracked by Wall St. Rank hold ERNA as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Eterna Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2 Eterna Therapeutics shares in Q1 2022, an estimated $56.
  • Manulife (Manufacturers Life Insurance) first reported a position in Eterna Therapeutics in Q2 2021 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Eterna Therapeutics position peaked at $252K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.